Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): Analysis of the phase III MAX study. Other Publication uri icon


  • Weickhardt, AJ
  • Williams, D
  • Lee, C
  • Simes, J
  • Murone, C
  • Wilson, K
  • Cummins, M
  • Asadi, K
  • Price, TJ
  • Mariadason, J
  • Tebbutt, NC
  • Australasian GI Trials Group

publication date

  • May 20, 2011